Peptide Companion
Back to catalog
Peptide Companion
single
Healing & Recovery
Vial: 60 mg

Cerebrolysin (60 mg Vial)

Cerebrolysin is a porcine brain‑derived peptide preparation containing low‑molecular‑weight neuropeptides and free amino acids that crosses the blood–brain barrier to support neuronal survival. It mimics endogenous neurotrophic factors (e.g., NGF, BDNF) and modulates neuroinflammatory mediators. This educational protocol presents a once‑daily subcutaneous approach using a practical dilution for clear insulin‑syringe measurements.

Detailed protocol below.

Dosing Schedule
WeekDaily Dose (mg)Units (per injection) (mL)
Week 120 mg (20,000 mcg)100 units (1.0 mL) × 1
Week 224 mg (24,000 mcg)60 units (0.6 mL) AM + 60 units (0.6 mL) PM
Week 328 mg (28,000 mcg)70 units (0.7 mL) AM + 70 units (0.7 mL) PM
Week 4+32 mg (32,000 mcg)80 units (0.8 mL) AM + 80 units (0.8 mL) PM
Supplies Needed
  • •Peptide Vials (Cerebrolysin, 60 mg each):
  • •Insulin Syringes (U‑100): Count based on injections per day (1–2 depending on dose).
  • •Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.
  • •Alcohol Swabs: One for the vial stopper + one for the injection site each administration.
References

  • International Peptide Society

    Cerebrolysin Monograph: mechanism, pharmacology, and clinical applications (2018)

    View source

  • Alzheimer’s Drug Discovery Foundation

    Cerebrolysin cognitive vitality report: evidence synthesis and safety overview (2016)

    View source

  • Zhang et al., Med Sci Monit (PMC)

    Meta‑analysis of Cerebrolysin efficacy and safety in acute ischemic stroke (2017)

    View source

  • Kurkin et al., PLOS One

    Neuroprotective action of Cerebrolysin in acute/chronic brain ischemia in rats (2021)

    View source

  • Espinoza et al., Behav Brain Res (PubMed)

    Cerebrolysin neuroprotection and neurorepair in diabetic rat model (2024)

    View source

  • CDC

    Injection safety: preventing unsafe injection practices in clinical settings (2024)

    View source

  • WHO

    Injection safety: best practices for healthcare providers guide (2016)

    View source

  • Ever Neuro Pharma

    Cerebrolysin dosage recommendation and storage specifications (SPC 2016)

    View source

  • NCBI Bookshelf

    Subcutaneous injection technique: preparation, administration, and site rotation

    View source

  • Subcutaneous Drug Delivery Review (PMC)

    Pharmacologic considerations and best practices for subcutaneous administration

    View source

  • Cognitive Frailty & Cerebrolysin Review (PMC)

    Evidence for peptidergic nootropics in age‑related cognitive decline

    View source

  • Neurotrophic Factors & Neurodegeneration (PMC)

    Role of NGF/BDNF pathways in neuroprotection and neuroplasticity

    View source

Educational content adapted from peptidedosages.com. Not medical advice.